JPS5873866A - Immunological method for detection - Google Patents

Immunological method for detection

Info

Publication number
JPS5873866A
JPS5873866A JP17146781A JP17146781A JPS5873866A JP S5873866 A JPS5873866 A JP S5873866A JP 17146781 A JP17146781 A JP 17146781A JP 17146781 A JP17146781 A JP 17146781A JP S5873866 A JPS5873866 A JP S5873866A
Authority
JP
Japan
Prior art keywords
reagent
capillary tube
agglutination
substance
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17146781A
Other languages
Japanese (ja)
Other versions
JPH0468588B2 (en
Inventor
Yasuo Murao
康雄 村尾
Shuntaro Hosaka
保坂 俊太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP17146781A priority Critical patent/JPS5873866A/en
Publication of JPS5873866A publication Critical patent/JPS5873866A/en
Publication of JPH0468588B2 publication Critical patent/JPH0468588B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE:To enable quick and highly sensitive detection and also preliminary preparation and preservation of a capillary tube with reagent therein by a method wherein a reagent for immune agglutination reaction is injected into the capillary tube, frozen and dried and are mixed with a solution to be analyzed, and then the capillary tube is laid horizontally in a stationary state to observe the state of agglutination. CONSTITUTION:A reagent (an antibody for an antigen, an antigen for an antibody, etc.) agglutinating in peculiar reaction to a substance to be measured (an antigen, an antibody, a complement component, etc.) is injected, as it is, into a capillary tube (a glass or plastic tube) having the inside diameter of 0.5-5mm. and the length of 50-100mm., or a reagent for immune agglutination reaction fixed on a carrier such as a glass or plastic grain or a red corpuscle is injected therein. Then it is frozen and dried in liquid nitrogen. The capillary tube, sealed up at both ends, can be preserved in the frozen state until an analysis is conducted. At the time of the analysis, the reagent dissolved or dispersed in water and then mixed with a solution to be analyzed or the four-times dilution thereof. Thereafter, the capillary tube is laid horizontally in a stationary state, and the state of agglutination thus generated is observed. When the agglutination (a) is present, the substance is positive, and when there is a state (b) that the reagent adheres to the wall of the tube, the substance is negative. Thus, the detection can be performed quickly and simply.

Description

【発明の詳細な説明】 本発明は免疫学的凝集反応を利用して、ヒト又は動物の
体液中の成分を検出ないし測定する方法に関する。抗原
と抗体との反応を利用してそのいずれか一方を免疫学的
に検出又は定量する場合に、測定したい物質に結合する
側の物質を適当な大きさの担体粒子に固定させておき、
その粒子が被測定物質の存在下に凝集を起こす現象を利
用して高感度の測定を行なう方法は免疫学的′儒床讐査
の重要な手段となっている。また逆に測定したい物質を
粒子に固定しておき、その被測定物質と特異的に反ニー
する抗原又は抗体の存在による被測定物質固定化粒子の
凝集が、被測定物質の存在により阻止されることにより
被測定物質を検出又は定置する方法も免疫学的臨床検査
において広く用いられている。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for detecting or measuring components in human or animal body fluids using immunological agglutination reactions. When using the reaction between an antigen and an antibody to immunologically detect or quantify either one of them, the substance that binds to the substance to be measured is immobilized on carrier particles of an appropriate size,
A highly sensitive measurement method that utilizes the phenomenon of particles aggregating in the presence of a substance to be measured has become an important means for immunological investigation. Conversely, the substance to be measured is immobilized on particles, and the presence of the substance to be measured prevents aggregation of the particles immobilized with the substance to be measured due to the presence of an antigen or antibody that specifically opposes the substance to be measured. Methods for detecting or positioning a substance to be measured are also widely used in immunological clinical tests.

従来、免疫活性物質固定化微粒子が検体液中の被測定成
分との反応により凝集するか否か、または予め準備され
た試薬と免疫活性物質固定化微粒子との反応による凝集
を検体液中の被測定成分が阻止するか否かという判定は
、主に平板上あるいはマイクロプレート上で検体と凝集
反応用試薬を混合する事により行なわれている。
Conventionally, it has been determined whether immunoactive substance-immobilized microparticles aggregate due to a reaction with a component to be measured in a sample fluid, or whether the immunoactive substance-immobilized microparticles aggregate due to a reaction between a pre-prepared reagent and immunoactive substance-immobilized microparticles in a sample fluid. Determination as to whether a component to be measured inhibits or not is mainly made by mixing the specimen and agglutination reaction reagent on a flat plate or microplate.

しかし平板上で凝集反応は非常に迅速でるるか感度が低
い。一方マイクロプレート上での凝集反応は感度が高い
が判定に要する時間が2時間以上と長い。
However, on flat plates, the agglutination reaction is very rapid or has low sensitivity. On the other hand, agglutination reactions on microplates have high sensitivity, but the time required for determination is long, 2 hours or more.

本発明者らは、これら従来の欠点を解決すべく、高感度
で判定時間が短く、かつ簡便な検査方法について検討し
た結果、本発明に到達した。
In order to solve these conventional drawbacks, the present inventors have studied a highly sensitive, short determination time, and simple inspection method, and as a result, they have arrived at the present invention.

すなわち本発明は、免疫学的凝集反応により体液中の成
分を検出又は定量する方法において、凝集反応試薬を毛
細管に注入し凍結乾燥させ、該毛細管中で検体と凝集反
応試薬を混合させることを特徴とする免疫学的検査方法
である。
That is, the present invention is a method for detecting or quantifying components in a body fluid by immunological agglutination reaction, which is characterized by injecting an agglutination reaction reagent into a capillary tube and freeze-drying it, and mixing the specimen and the agglutination reaction reagent in the capillary tube. This is an immunological testing method that

本発明で用いられる凝集反応試薬とは、測定したい物質
に特異的に結合する物質、あるいは測定したい物質を担
体に固定化させたものである。これら担体に固定化させ
る物質としては、例えば梅毒トレポネーマ抗原、リウマ
チ因子、B型肝炎表面抗原(HBs抗原)、HBs抗原
に対する抗体(抗HBs抗体)、トキソプラズマ抗原、
ストレグトリジン−〇、抗ストレプトリジン0抗体、マ
イコプラズマ抗原、ヒト繊毛性ゴナドトロピン(HCG
)、抗HCG抗体、熱凝集ヒト免疫グロブリンG1核蛋
白、デオキシ核酸、抗C反応性蛋白抗体、エストロゲン
、抗エストロゲン抗体、補体成分(C1q 、C1r 
、C1s 、C2゜C5、C4、C5、C6、C7、C
8、C9)およびそれらに対する抗体などの゛免疫活性
物質が挙げられる。担体としては、血球(ホルマリン等
によシ固定)、菌体、ポリスチレ、ラテックユ、その他
ポリマーマイクロビーズ等が挙げられる。
The agglutination reaction reagent used in the present invention is a substance that specifically binds to a substance to be measured, or a substance in which the substance to be measured is immobilized on a carrier. Substances to be immobilized on these carriers include, for example, Treponema pallidum antigen, rheumatoid factor, hepatitis B surface antigen (HBs antigen), antibody against HBs antigen (anti-HBs antibody), Toxoplasma antigen,
Streptolysin-○, anti-streptolysin 0 antibody, mycoplasma antigen, human ciliated gonadotropin (HCG)
), anti-HCG antibody, heat-agglutinated human immunoglobulin G1 nuclear protein, deoxynucleic acid, anti-C-reactive protein antibody, estrogen, anti-estrogen antibody, complement components (C1q, C1r
, C1s , C2゜C5, C4, C5, C6, C7, C
8, C9) and antibodies against them. Examples of carriers include blood cells (fixed with formalin, etc.), bacterial cells, polystyrene, latex, and other polymer microbeads.

免疫活性物質の担体への固定化は、物理吸着イオン結合
または共有結合によって行なわれる。
Immobilization of the immunologically active substance onto the carrier is performed by physically adsorbed ionic bonding or covalent bonding.

本発明検査方法で用いる毛細管は、0.5〜5TIrI
n好ましくは約1mmの均一な内径を有し、さらに好ま
しくは50〜100mmの長さのガラス又はポリメチル
メタクリレート、ポリスチレン、ポリカーボネート、ポ
リ塩化ビニル、ポリスルポン等のプラスチックを材質と
する透明な管状物である。
The capillary tube used in the testing method of the present invention is 0.5 to 5 TIrI
A transparent tubular body made of glass or plastic such as polymethyl methacrylate, polystyrene, polycarbonate, polyvinyl chloride, polysulfone, etc., preferably having a uniform inner diameter of about 1 mm, and more preferably a length of 50 to 100 mm. be.

この毛細管は、検体あるいは凝集反応用試薬を一定量吸
入する目的でピストンあるいはキャップ状ピペッタ−1
さらに目盛を備えている方が好ましい。
This capillary is connected to a piston or cap-shaped pipettor for the purpose of inhaling a fixed amount of a sample or agglutination reaction reagent.
Furthermore, it is preferable to have a scale.

本発明では毛細:管に凝集反応試薬を注入した、:。In the present invention, an agglutination reaction reagent is injected into a capillary tube.

後、該試薬を凍結乾燥する。凍結乾燥法は通常′等。Afterwards, the reagent is lyophilized. The freeze-drying method is usually 'etc.

の方法で構わないが・、液体窒素中で凍結させる方が好
ましい。凝集反応は、血清または血漿等の検体を毛細管
に注入し、凝集反応試薬と混合させて行なう。凍結乾燥
した凝集反応用試薬は、検体と混合させる前に水で溶解
させることが好筐しい。凝集反応には、従来から知られ
ている凝集反応用添加剤を添加することももちろん可能
である。検体と試薬を充分に混合させた後、毛細管をほ
ぼ水平方向に静置させると、数十分後には(+)像と(
→像を判別できる沈降像が得られる0 本発明は、U字型マイクロプレートと同程度の高感度を
示し、しかも判定に要する時間を短縮できるという優れ
た検査方法であり、また凍結乾燥した凝集反応用試薬は
保存性が良いため、予め調整しておくと、検体を毛細管
に注入するだけで検査ができるという利点もめる。
However, it is preferable to freeze in liquid nitrogen. The agglutination reaction is performed by injecting a sample such as serum or plasma into a capillary tube and mixing it with an agglutination reaction reagent. It is preferable to dissolve the freeze-dried agglutination reaction reagent in water before mixing it with the specimen. It is of course possible to add conventionally known additives for aggregation reactions to the aggregation reaction. After thoroughly mixing the sample and reagent, if the capillary tube is left standing in an almost horizontal direction, a (+) image and a (
→A sedimentation image that can be distinguished is obtained.0 The present invention is an excellent inspection method that exhibits high sensitivity comparable to that of a U-shaped microplate and can shorten the time required for determination. Reaction reagents have a good shelf life, so if they are prepared in advance, they can be tested by simply injecting the sample into a capillary tube.

以下実施例を挙げて本発、明を更に具体的に説明する。The present invention will be described in more detail below with reference to Examples.

実施例1゜ 内径1.2■、高さ75簡のガラス製へマドクリット管
中に梅毒HA抗原(富士臓器製薬)の抗原感作ヒツジ血
球浮遊液を10μを採り液体窒素中で凍結し減圧乾燥し
た。管中Vζ仏留水10μtを注入して感作血球を再分
散した後血清希釈液で希釈した血清を10μt 注入し
管軸方向に管を上下して充分に混合し、水平面上に静置
した。30分後の判定結果を表1および第1図に示す。
Example 1 A 10μ sample of a suspension of syphilis HA antigen (Fuji Organ Pharmaceutical Co., Ltd.) sensitized sheep blood cells was taken into a glass hemadocrit tube with an internal diameter of 1.2cm and a height of 75mm, frozen in liquid nitrogen, and dried under reduced pressure. did. After injecting 10 μt of Vζ distilled water into the tube to redisperse the sensitized blood cells, 10 μt of serum diluted with serum diluent was injected, the tube was moved up and down in the axial direction to mix thoroughly, and the tube was left standing on a horizontal surface. . The determination results after 30 minutes are shown in Table 1 and FIG.

第1図中、(a)は陽性(−F)、(b)は陰性(=)
第2図は第1図と同様(a)が陽性、(b)が陰性を示
す。マイクロプレートの場合は、判定に18時間要した
In Figure 1, (a) is positive (-F), (b) is negative (=)
In FIG. 2, as in FIG. 1, (a) indicates positive and (b) indicates negative. In the case of a microplate, it took 18 hours for the determination.

表    1 ※管内における最終希釈倍率 実施例2゜ 実施例1と同様のへマドクリット管中に特願昭55−5
8677に記載のBSA固定化ポリマーマイクロビーズ
分散液10μtを採り凍結乾燥した。管中に蒸留水10
μtを注入してBS/固定化ポリマーマイクロビーズを
再分散した後200μノAb/m7?の抗BSA抗血清
(兎)のリン酸緩衝生理食塩水溶液10μt を採って
管軸方向に上下して充分に混合し、水平面上に静置した
。なお、陰性対照として抗BSA抗血清(兎)をBSA
のリン酸緩衝生理食塩水溶液(BSA111+9/m/
  )で同率に希釈し使用した。
Table 1 *Final dilution ratio in the tube Example 2
10 μt of the BSA-immobilized polymer microbead dispersion described in No. 8677 was taken and freeze-dried. Distilled water in the tube 10
After redispersing the BS/immobilized polymer microbeads by injecting μt 200μ Ab/m7? 10 μt of a phosphate-buffered saline solution of anti-BSA antiserum (rabbit) was taken, mixed thoroughly by moving it up and down in the axial direction of the tube, and the tube was placed on a horizontal surface. In addition, as a negative control, anti-BSA antiserum (rabbit) was used as a negative control.
Phosphate buffered saline solution (BSA111+9/m/
) and diluted to the same ratio and used.

20分後に判定するとリン酸緩衝生理食塩水溶液にBS
Aを添加した陰性対照は第1図の(−)像を示し、BS
Aを添加しなかった試料は(−11像を示した。
BS in phosphate buffered saline solution as determined after 20 minutes.
The negative control added with A shows the (-) image in Figure 1, and the BS
The sample to which A was not added showed a (-11 image).

実施例5゜ ヘマトクリット管中に特願昭55−58677に記載の
梅毒抗原固定化ポリマーマイクロビーズ分散液を10μ
を採り管両端にキャップを付けて冷蔵庫中に保存した。
Example 5 In a hematocrit tube, 10μ of the syphilis antigen-immobilized polymer microbead dispersion described in Japanese Patent Application No. 58677/1986 was placed.
The tube was collected with caps on both ends and stored in the refrigerator.

管両端のキャップを取り、血清希釈液により4o倍に希
釈したTPHA力価1280の血清を1oμを採って管
軸方向に上下して充分に混合し、水平面上に静置した。
The caps at both ends of the tube were removed, and 1 μm of serum with a TPHA titer of 1280 diluted 40 times with a serum diluent was taken, mixed thoroughly by moving up and down in the axial direction of the tube, and the tube was allowed to stand still on a horizontal surface.

L  対照として陰性血清で同じ操作をくり返した02
0分後に判定すると陽性血清では(−+)像が、陰性血
清では(−)像が得られた。
L The same procedure was repeated with negative serum as a control 02
When judged after 0 minutes, a (-+) image was obtained for positive serum, and a (-) image was obtained for negative serum.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明方法による検査結果を示す拡大縦断面図
であり、第2図は従来法のマイクロプレートによる方法
の検査結果を示す拡大平面図である。各々(a)は十像
、(b)は−像を示す。 特許出願人  東 し 株 式 会 社(幻     
   ( !71 図 (0L) 第2 わ
FIG. 1 is an enlarged longitudinal sectional view showing the test results obtained by the method of the present invention, and FIG. 2 is an enlarged plan view showing the test results obtained by the conventional method using a microplate. (a) shows ten images, and (b) shows - images, respectively. Patent applicant Toshi Co., Ltd. (phantom)
(!71 Figure (0L) 2nd wa

Claims (1)

【特許請求の範囲】[Claims] (1)免疫学的凝集反応により体液中の成分を検出また
は定量する方法において、凝集反応試薬を毛細管に注入
し凍結乾燥させ、該毛細管中で検体と凝集反応試薬を混
合させることを特徴とする免疫学的検査方法。
(1) A method for detecting or quantifying components in body fluids by immunological agglutination reaction, which is characterized by injecting an agglutination reagent into a capillary tube, freeze-drying it, and mixing the sample and agglutination reaction reagent in the capillary tube. Immunological testing method.
JP17146781A 1981-10-28 1981-10-28 Immunological method for detection Granted JPS5873866A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17146781A JPS5873866A (en) 1981-10-28 1981-10-28 Immunological method for detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17146781A JPS5873866A (en) 1981-10-28 1981-10-28 Immunological method for detection

Publications (2)

Publication Number Publication Date
JPS5873866A true JPS5873866A (en) 1983-05-04
JPH0468588B2 JPH0468588B2 (en) 1992-11-02

Family

ID=15923641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17146781A Granted JPS5873866A (en) 1981-10-28 1981-10-28 Immunological method for detection

Country Status (1)

Country Link
JP (1) JPS5873866A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62102156A (en) * 1985-10-24 1987-05-12 ヒユ−・ブイ・コツチンガム Agglomeration reaction chamber for liquid particle reagent
WO1990007716A1 (en) * 1988-12-23 1990-07-12 Toray Industries, Inc. Immunological inspection tube
US5656506A (en) * 1990-07-13 1997-08-12 Canon Kabushiki Kaisha Dry detection reagent containing acrylamide/styrene copolymer particles immobilizing an immunologically active substance
US5679581A (en) * 1989-08-23 1997-10-21 Canon Kabushiki Kaisha Method for measuring an immunologically active material and apparatus suitable for practicing said method
US7850917B2 (en) 2008-03-11 2010-12-14 Ortho-Clinical Diagnostics, Inc. Particle agglutination in a tip

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4117920Y1 (en) * 1964-03-09 1966-08-19
JPS52117420A (en) * 1976-03-25 1977-10-01 Hoffmann La Roche Preparation of latex binding serum physiologically determining substance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4117920Y1 (en) * 1964-03-09 1966-08-19
JPS52117420A (en) * 1976-03-25 1977-10-01 Hoffmann La Roche Preparation of latex binding serum physiologically determining substance

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62102156A (en) * 1985-10-24 1987-05-12 ヒユ−・ブイ・コツチンガム Agglomeration reaction chamber for liquid particle reagent
JPH0616045B2 (en) * 1985-10-24 1994-03-02 ヒユ−・ブイ・コツチンガム Liquid particle reagent agglutination slide
WO1990007716A1 (en) * 1988-12-23 1990-07-12 Toray Industries, Inc. Immunological inspection tube
US5679581A (en) * 1989-08-23 1997-10-21 Canon Kabushiki Kaisha Method for measuring an immunologically active material and apparatus suitable for practicing said method
US5656506A (en) * 1990-07-13 1997-08-12 Canon Kabushiki Kaisha Dry detection reagent containing acrylamide/styrene copolymer particles immobilizing an immunologically active substance
US7850917B2 (en) 2008-03-11 2010-12-14 Ortho-Clinical Diagnostics, Inc. Particle agglutination in a tip
US8048376B2 (en) 2008-03-11 2011-11-01 Ortho-Clinical Diagnostics, Inc. Particle agglutination in a tip
US8273297B2 (en) 2008-03-11 2012-09-25 Ortho-Clinical Diagnostics, Inc. Particle agglutination in a tip

Also Published As

Publication number Publication date
JPH0468588B2 (en) 1992-11-02

Similar Documents

Publication Publication Date Title
US5236826A (en) Immunoassay for the detection or quantitation of an analyte
US4521521A (en) Particle reagent size distribution measurements for immunoassay
US5501949A (en) Particle bound binding component immunoassay
US4138474A (en) Method and device for immunoassay
US4348207A (en) Method and means for determination of pregnancy
EP0248892A1 (en) Particle-bound binding component immunoassay
JPS6243138B2 (en)
EP0070527B1 (en) Method of assaying biologically active substances and labelling agents therefor
Gella et al. Latex agglutination procedures in immunodiagnosis
JPS6365369A (en) Method for measuring antigen-antibody reaction
BR112020016548A2 (en) IN VITRO DIAGNOSTIC DEVICE, USE OF THE SAME AND IN VITRO METHODS
JP2021505887A (en) Lateral flow assays and methods for detecting high concentrations of analytes
JPS5873866A (en) Immunological method for detection
JP4086266B2 (en) Immunoassay method
EP0609265A1 (en) Unit-of-use reagent composition for specific binding assays.
US4792527A (en) Method of assaying biologically active substances and labelling agents therefor
JPH08262024A (en) Kit for immunoassay of in vivo substance and immunoassay method
JP3220546B2 (en) Method for measuring antigen or antibody in the presence of immune complex
JP4556605B2 (en) Target substance measurement method and reagent
JP3916189B2 (en) Reagent for immunoassay and immunoassay
EP0607209A1 (en) Unit-of-use reagent compositions for specific binding assays
JPS6262291B2 (en)
CN116380881B (en) Kit for photo-activated chemical detection, kit and use method thereof
JP3618797B2 (en) Immunoassay
JPH09304386A (en) Manufacture of immunity diagnostic drug and immunity diagnostic drug obtained